Literature DB >> 3939157

MHC-unrestricted cytolytic T lymphocytes.

A M Krensky, C Clayberger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3939157     DOI: 10.1007/bf02918737

Source DB:  PubMed          Journal:  Surv Immunol Res        ISSN: 0252-9564


× No keyword cloud information.
  20 in total

1.  Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones.

Authors:  J Ritz; T J Campen; R E Schmidt; H D Royer; T Hercend; R E Hussey; E L Reinherz
Journal:  Science       Date:  1985-06-28       Impact factor: 47.728

Review 2.  Diagnostic and therapeutic implications of T cell surface antigens.

Authors:  A M Krensky; C Clayberger
Journal:  Transplantation       Date:  1985-04       Impact factor: 4.939

3.  In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.

Authors:  G F Burns; T Triglia; J A Werkmeister
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

Review 4.  Lymphokine-driven "differentiation" of cytotoxic T-cell clones into cells with NK-like specificity: correlations with display of membrane macromolecules.

Authors:  C G Brooks; D L Urdal; C S Henney
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

5.  Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity.

Authors:  P C Doherty; R V Blanden; R M Zinkernagel
Journal:  Transplant Rev       Date:  1976

6.  Target specificity and cell surface structures involved in the human cytolytic T lymphocyte response to endothelial cells.

Authors:  C Clayberger; T Uyehara; B Hardy; J Eaton; M Karasek; A M Krensky
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

7.  Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

Authors:  S A Rosenberg; M T Lotze; L M Muul; S Leitman; A E Chang; S E Ettinghausen; Y L Matory; J M Skibber; E Shiloni; J T Vetto
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

8.  Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.

Authors:  L L Lanier; A M Le; J H Phillips; N L Warner; G F Babcock
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

9.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

Authors:  B Perussia; S Starr; S Abraham; V Fanning; G Trinchieri
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

10.  Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.

Authors:  A Moretta; G Pantaleo; M C Mingari; L Moretta; J C Cerottini
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

View more
  2 in total

1.  MHC nonrestricted cytotoxic T cell clones with selective specificity from patients with transitional cell carcinoma (TCC) of the urinary bladder.

Authors:  Y Hansson; M Vargas-Cortes; S Paulie; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 2.  Cytotoxic cellular mediators of the immune response to neoplasia: a review.

Authors:  P Khavari
Journal:  Yale J Biol Med       Date:  1987 Sep-Oct
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.